Chubb Limited
—- Market cap
- $132.50B
- Debt
- +$17.23B
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 88% equity / 12% debt
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt cap
Decision snapshot: CB stock price at discount vs ROIV $341.63 current versus $468.08K implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ROIV's multiple
Implied fair value · at CB's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: CB FY 2025 (ended Dec 31, 2025) · ROIV FY 2026 (ended Mar 31, 2026). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 88% equity / 12% debt
Capital structure 98% equity / 2% debt · EV / Revenue 2586.72x
CB carries the larger enterprise value at $149.73B against $21.37B; CB trades on the lower EV / Revenue multiple (2.52x vs 2586.72x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
CHUBB LIMITED · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
ROIVANT SCIENCES LTD. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.23x
0.09x
Net debt / EBITDA
Leverage against operating earnings
—
24.52x
Cash and equivalents
Liquid reserves on the balance sheet
—
$4.29B
Total debt
Interest-bearing obligations outstanding
$17.23B
$412.94M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AMERICAN INTERNATIONAL GROUP, INC.
CB vs AIG
ALLSTATE CORP
CB vs ALL
HARTFORD FINANCIAL SERVICES GROUP, INC.
CB vs HIG
PROGRESSIVE CORP/OH/
CB vs PGR
CINCINNATI FINANCIAL CORP
CB vs CINF
Arthur J. Gallagher & Co.
CB vs AJG
Revolution Medicines, Inc.
CB vs RVMD
INCYTE CORP
CB vs INCY
Sarepta Therapeutics, Inc.
CB vs SRPT
EXELIXIS, INC.
CB vs EXEL
VERTEX PHARMACEUTICALS INC / MA
CB vs VRTX
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.